Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Bi-sdAb) is designed to be expressed as a VHH from anti-EGFR antibody variable domains fused with a VHH from an anti-HER2 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Breast cancer; Colon cancer; Lung cancer; Pancreatic cancer; Gastric cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-EGFR VHH x Anti-HER2 VHH BispecificAntibody (Bi-sdAb) (BIVHH-045). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS